MiCo BioMed Co Ltd Intrinsic Valuation and Fundamental Analysis - MiCo BioMed Co Ltd

Watchlist Manager

Watchlist

Price: 2 290 KRW -2.35%

Market Cap: ₩19.2B

M	MiCo BioMed Co Ltd KOSDAQ:214610	KR
A	Adiuvo Investments SA WSE:ADV	PL
	Doxa AB F:1DO	SE
C	China Merchants Port Holdings Co Ltd F:CPM	HK
	OFS Capital Corp NASDAQ:OFS	US
A	AES Corp XMUN:AES	US
S	Sixt SE F:SIX2	DE
F	FutureFuel Corp SWB:3FF	US
N	Novartis AG XMUN:NOT	CH
C	China Merchants Port Holdings Co Ltd XMUN:CPM	HK
F	FutureFuel Corp F:3FF	US
S	Sega Sammy Holdings Inc XMUN:RYU	JP
A	Adidas AG XMUN:ADS	DE

Intrinsic Value

Is MiCo BioMed Co Ltd undervalued or overvalued?

See the intrinsic value estimate for MiCo BioMed Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

MiCo BioMed Co Ltd Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with MiCo BioMed Co Ltd’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price ₩2 290

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What MiCo BioMed Does

Health Care

MiCo BioMed Co. Ltd. engages in the development, manufacture and sale of in vitro diagnosis medical devices and diagnostic reagents. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2015-06-22. The firm operates its business through three segments. The Molecular Diagnosis segment mainly manufactures and sells products such as nucleic acid extraction equipment, gene amplification equipment, reagents, and lab chips.

Headquarters: Korea KR
IPO date: Jun 22, 2015